Waystar to Acquire Iodine Software for $1.25 Billion
Waystar has announced a definitive agreement to acquire 100% of Iodine Software for a total enterprise value of $1.25 billion, announced in a press release. This acquisition is expected to accelerate Waystar's transformation of healthcare payments through its cloud-based software platform, which aims to prevent denials, reduce manual work, and improve financial performance.
Iodine Software is known for its AI-powered clinical intelligence software, which is trusted by many of the nation's premier health systems. The integration of Iodine's capabilities is projected to expand Waystar's total addressable market by more than 15% and enhance its AI innovation with clinical intelligence.
The transaction, expected to close by the end of 2025, will be funded with a mix of cash and stock consideration. Upon completion, Waystar shareholders will own approximately 92% of the combined company, while Iodine equity holders will own about 8%. This strategic move is anticipated to strengthen Waystar's financial profile and deepen its relationships with leading hospitals and health systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 20 Danaher and Microsoft build an agentic platform for lab instruments Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AIMore from Funding
Nov 20 Hoplite raises $5.5 million from Stripe's Collison brothers to run AI coding agents in the cloud Nov 20 hackajob raises $10 million to expand Archer, its AI recruiting agent Nov 20 Protesters rally against Anthropic in New York and San Francisco on its stock market debut Nov 19 Anthropic's IPO could channel about $156 billion to charity, TechCrunch estimates Nov 19 Sierra reportedly in talks to raise at a $30 billion valuationLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Isomorphic Labs Seeks $5 Billion at $50 Billion Valuation
Wolters Kluwer to buy AI clinical decision support company AgileMD for up to $100 million
INVE Technologies Partners With Trackonomy on Physical AI Software
Intel to Acquire Classiq for $2.3 Billion
Tristar AI raises $12.4 million for real-time AI quality inspection on factory lines
Daily AI Brief: the AI news that matters, in your inbox.